Lactation Ibclc denied as not FDA-approved for this use by Cigna?

Cigna's specific coverage criteria for lactation ibclc are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied This Claim: Not FDA-Approved

Applying a "not FDA-approved" denial to IBCLC lactation consultant services is a classification error — FDA approval governs drugs and devices, not professional healthcare services. An International Board Certified Lactation Consultant is a credentialed healthcare professional, and the services they provide are clinical consultations, not regulated products. When this language appears on a denial for a lactation visit, it typically indicates a billing code mismatch, a plan-exclusion misapplication, or an automated claims-processing error. This type of denial is generally straightforward to reverse because the premise is factually inapplicable to the service billed.

## Your Federal Appeal Rights

• Internal appeal (ACA §2719 / ERISA §503): File within 180 days of Cigna's denial. Cigna must respond within 30–60 days for standard appeals or 72 hours for urgent reviews.
• External review (ACA §2719): After any adverse internal determination, you are entitled to independent external review by an organization not affiliated with Cigna. The window for requesting external review is typically 4 months from the internal denial date — confirm the exact deadline on your EOB. External reviewers are not bound by Cigna's internal policies and assess consistency with generally accepted medical standards.
• Expedited external review is available when delay would seriously jeopardize health.

## Why This Denial Cannot Stand

The ACA requires that non-grandfathered health plans cover breastfeeding support and supplies, as defined in the HRSA Women's Preventive Services Guidelines. That mandate covers comprehensive lactation support provided by a trained provider — which an IBCLC meets by credential definition. An "FDA approval" filter simply does not apply to professional services. Your appeal should make this point clearly and briefly, then pivot to the positive coverage argument.

## Documentation to Gather

1. Cigna's denial letter — identify the exact policy provision or automated reason code cited. If it references a specific exclusion, obtain that exclusion's full text. 2. Your Summary of Benefits and Coverage (SBC) — confirms that lactation support is listed as a covered preventive benefit and under what conditions. 3. HRSA Women's Preventive Services Guidelines — publicly available; cite the specific recommendation covering comprehensive lactation support and counseling. 4. IBCLC credential documentation — confirms the provider's board certification and that this is a licensed professional service, not a product subject to FDA review. 5. IBCLC visit notes — confirms the clinical services rendered and the specific breastfeeding problem addressed. 6. Prescriber or pediatrician letter — supporting clinical necessity if Cigna raises a secondary medical-necessity argument at the appeal stage.

## Criteria-Mapping Structure

| Denial Basis | Rebuttal Evidence | |---|---| | "FDA approval" inapplicable to professional services | Explanation of FDA regulatory scope + IBCLC credential | | ACA preventive mandate requires coverage | SBC + HRSA Guideline citation | | Service meets covered benefit definition | Visit notes + credential documentation | | No applicable plan exclusion | Full text of cited exclusion (if any) vs. actual service rendered |